Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Wnt pathway
Research
Surrozen's Wnt mimetic antibody works in mice with lung fibrosis
The results, published in the journal Respiratory Research, are an early signal of a potential new indication for the company’s SWAP technology.
Helen Floersh
Apr 4, 2024 4:30am
Boehringer pledges $599M for Surrozen's eye disease asset
Oct 6, 2022 11:00am
Targeting blood vessels to beat resistant glioblastoma
Feb 26, 2020 2:00pm
FogPharma beefs up R&D team with new CSO, discovery head
May 6, 2019 11:54am
Redx cleared to start Wnt cancer trial again after safety scare
Jan 21, 2019 9:05am